915 abstracts found.



Results filter

Febrile neutropaenia in patients receiving TAC chemotherapy for breast cancer

Year:

Session type:

Jessica Scaife, Rebecca Matthews, Peter Jenkins

Gloucestershire Oncology Centre, Cheltenham General Hospital, Cheltenham, Gloucestershire, UK


Does breast reconstruction improve quality of life for women facing mastectomy? A systematic review

Year:

Session type:

Shelley Potter, Zoe Winters

University of Bristol, Bristol , UK


Does the cosmetic outcome of breast reconstruction influence patient satisfaction or quality of life? A comparison of patients and healthcare professionals perspectives

Year:

Session type:

Shelley Potter1, Helen Thomson1, Rosemary Greenwood2, Simon Cawthorn3, Mark Beresford4, Marilyn Calder1, Zenon Rayter2, Zoe Winters1

1University of Bristol, Bristol, UK, 2United Bristol Healthcare Trust, Bristol, UK, 3Frenchay Hospital, Bristol, UK, 4Bristol Haematology and Oncology Centre, Bristol, UK


Beta-catenin independent Wnt signalling in colorectal cancer

Year:

Session type:

Germaine Caldwell, Carolyn Jones, Dion Morton, Glenn Matthews

University of Birmingham, UK


Generation of a fully human anti-CD20 antibody with improved effector function, through the combined use of Xenomouse and ribosome display technologies

Year:

Session type:

Ross Stewart1, George Thom1, John Lund1, Michaela Levens1, Gulin Guler-Gane1, Sarahya Raja2, Shenghua Wen2, Christophe Queva2, Naomi Laing2, Anne Van Abbema2, Ping Wang4, Carlos Chavez4, Larry L Green4, Xiaoadong Yang4, Mohammad Tabrizi3, Gadi Gazit-Bornstein2, David Blakey1, Carl Webster1

1MedImmune, Cambridge, UK, 2Astrazeneca, Waltham, MA, USA, 3MedImmune, Hayward, CA, USA, 4Amgen, Fremont, CA, USA


A rapid and sensitive assay to detect RET M918T mutations in tumor samples from patients with sporadic medullary thyroid cancer

Year:

Session type:

James Sherwood, Gillian Ellison, John C Smith, Alan Wookey, Anderson Ryan

AstraZeneca, Alderley Park, UK


The removal of multiplicative, systematic bias allows integration of breast cancer gene expression datasets – improving meta-analysis and prediction of prognosis

Year:

Session type:

Andrew Sims1, Graeme Smethurst2, Yvonne Hey2, Michal Okoniewski2, Stuart Pepper2, Anthony Howell3, Crispin Miller2, Robert Clarke2

1University of Edinburgh, UK, 2University of Manchester, UK, 3Christie Hospital, Manchester, UK


In vitro chemosensitivity of leukaemic stem and progenitor cells to gemtuzumab ozogamicin (Mylotarg) in acute myeloid leukaemia

Year:

Session type:

Mays Jawad1, Ullas Mony1, Nigel H. Russell2, Monica Pallis2

1Division of Haematology, University of Nottingham, Nottingham, UK, 2Department of Clinical Haematology, Nottingham University Hospitals, Nottingham, UK


Investigating BRCA1 as a breast stem cell regulator

Year:

Session type:

Caoimhe Nic An tSaoir, Niamh O'Brien, Keara Redmond, Paul Mullan

Queen's University, Belfast, UK


VEGF autocrine signalling maybe involved in proliferation of tumour initiating cells

Year:

Session type:

Emma Kenney-Herbert, Siolian Ball, Colin Watts

Brain Repair Centre, Cambridge, UK


Page 25 of 92« First...25...50...Last »